- Home
- BNZI vs CING Comparison
BNZI vs CING Comparison
Compare BNZI & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- CING
- Stock Information
- Founded
- BNZI 2016
- CING 2012
- Country
- BNZI United States
- CING United States
- Employees
- BNZI N/A
- CING N/A
- Industry
- BNZI
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- CING Health Care
- Exchange
- BNZI Nasdaq
- CING Nasdaq
- Market Cap
- BNZI 16.4M
- CING 16.2M
- IPO Year
- BNZI N/A
- CING 2021
- Fundamental
- Price
- BNZI $1.01
- CING $3.97
- Analyst Decision
- BNZI Strong Buy
- CING Strong Buy
- Analyst Count
- BNZI 1
- CING 4
- Target Price
- BNZI $26.00
- CING $30.67
- AVG Volume (30 Days)
- BNZI 816.7K
- CING 125.0K
- Earning Date
- BNZI 05-15-2025
- CING 05-08-2025
- Dividend Yield
- BNZI N/A
- CING N/A
- EPS Growth
- BNZI N/A
- CING N/A
- EPS
- BNZI N/A
- CING N/A
- Revenue
- BNZI $4,527,879.00
- CING N/A
- Revenue This Year
- BNZI $430.54
- CING N/A
- Revenue Next Year
- BNZI N/A
- CING N/A
- P/E Ratio
- BNZI N/A
- CING N/A
- Revenue Growth
- BNZI N/A
- CING N/A
- 52 Week Low
- BNZI $0.74
- CING $1.80
- 52 Week High
- BNZI $19.75
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- BNZI 46.38
- CING 51.56
- Support Level
- BNZI $0.98
- CING $3.82
- Resistance Level
- BNZI $1.07
- CING $4.15
- Average True Range (ATR)
- BNZI 0.06
- CING 0.30
- MACD
- BNZI 0.00
- CING -0.01
- Stochastic Oscillator
- BNZI 19.44
- CING 56.37
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.